Prior to the completion of the QT, Cheelcare completed a private placement of convertible debentures resulting in the issuance of the following securities in the resulting issuer.

Financing type:  non-brokered private placement

Gross proceeds:  $502,999.50

Offering:  894,217 listed shares

Offering price:  56.25 cents per listed share

Disclosure:  refer to the company's news releases dated Feb. 26, 2025, June 30, and July 14, 2025